Innovative food company Meatable has entered into a joint development agreement with Dutch multinational Royal DSM, a global purpose-led, science-based company active in nutrition, health and sustainable living, to co-develop growth media for cultivated meat. Growth media is a nutrient-rich liquid which contains the essential nutrients such as carbohydrates, proteins, salts, vitamins, and growth factors that cells need to grow.
Growth media is currently estimated to account for 50-90% of the production cost of cultured meat. If pivotal technological and cost breakthroughs are achieved, cultured meat could be one solution that helps support diversified, sustainable, and healthy diets for a growing world population – and will have a trillion-dollar market potential.
Wim Klop, Vice President DSM Biotechnology Center, says, ‘’Protein is an essential part of a balanced diet and vital for good health. Yet its production has a big environmental footprint. With the world population expected to grow to 10 billion people by 2050, a wide variety of solutions for more sustainable proteins will be needed. Cultivated meat is one of those promising, innovative protein solutions in which DSM invests. Our commitment goes way beyond investing in Meatable through DSM Venturing. With this joint development agreement DSM will contribute its unique competencies in biotechnology, such as fermentation, analysis and production scale-up to help make the science of cultivated meat a reality.”
In addition to focusing on the cost-effective production of growth media, DSM and Meatable will focus on the development of meat-like taste and texture of the final product, which are important factors influencing the purchase decision of consumers.
“With traditional animal farming alone, we will not be able to meet the growing demand for meat worldwide; we need breakthrough solutions. Cultivated meat has the potential to provide the growing world population with the protein source many people love – meat – using an efficient and sustainable production process that respects animal health and welfare,” says Krijn de Nood, CEO and co-founder of Meatable. “Joining forces with DSM, a global leader in biotechnology, will accelerate our research and development trajectory significantly. Together, we aim to develop the right nutritional ingredients in a fundamentally more cost effective and scalable process, to become the leading consumer choice for cultivated meat.”
DSM Venturing, the venture capital arm of Royal DSM, was a participant in the consortium of funders of Meatable’s recent raise of $47 million in venture capital. Meatable aims to produce cultivated meat for which animal health and welfare are respected, fewer GHG emissions are released, and significantly less land and water are required. Cultivated meat replicates the natural process of fat and muscle growth, in proportions that emulate traditional cuts of meat. The end-product will provide the full experience of eating actual meat, with the same texture, taste, and nutritional benefits, without harm to animals or the planet.
Fri 03 Dec 2021
With Cellular Agriculture Europe we believe to be part of a powerful tool that will help create a healthier and greener food system in Europe.
Tue 23 Mar 2021
Consortium of life sciences and food investors including Section 32, DSM Venturing, Dr. Rick Klausner, Dr. Jeffrey Leiden and existing investors support Meatable for its next phase of growth.
Fri 06 Dec 2019
BlueYard Capital, the Eurostars Programme by the European Commission, and angel VCs Taavet Hinrikus (founding CEO, TransferWise) and Albert Wenger (Union SquareVentures) are among the investors to contribute seed funds to accelerate developmentof the company’s first pork prototype.